Moreover, we showed increased autoantibody levels in patients with colonic CD compared to symptomatic controls and healthy controls in the discovery cohort, though this difference did not reach statistical significance in the validation cohort.
← all excerpts
Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype.
1
—
—